Psychopharmacology

Psychotherapy

Tantalizingly Close: An Update on Emerging Psychedelic Research and a Report from a Psychedelic Psychotherapist Trainee

Friday, October 26
9:15 AM - 10:30 AM
Location: Tangerine WF4

Clinical research into the use of psychedelics—MDMA, psilocybin, ketamine—in mental health has generated tremendous interest in our field. How do these pharmacologically disparate compounds, united by their ability to change consciousness, affect such significant change when coupled with preparatory and integrative psychotherapy? This session will provide an overview of recent advances in psychedelic research that begin to answer this question. Mr. Penn was a graduate of the second cohort of psychedelic psychotherapist trainees prepared by the California Institute of Integral Studies Center for Psychedelic Psychotherapies and Research and will provide valuable insights into the process of training clinicians to do this work of the future of psychiatry.

Andrew Penn, RN, MS, NP, APRN-BC

Associate Clinical Professor
University of California, San Francisco, School of Nursing
University of California, San Francisco, School of Nursing
Redwood City, CA

Andrew Penn, RN, MS, NP, APRN-BC, was trained as an adult nurse practitioner and psychiatric clinical nurse specialist at the University of California, San Francisco. He is board certified as an adult nurse practitioner and psychiatric nurse practitioner by the American Nurses Credentialing Center. Currently, he serves as an Associate Clinical Professor at the University of California-San Francisco School of Nursing where he teaches psychopharmacology. Mr. Penn is also a psychiatric nurse practitioner with Kaiser Permanente in Redwood City, California, where he provides medication and psychotherapeutic treatment for adult patients and specializes in the treatment of affective disorders and trauma. He is a former board member of the American Psychiatric Nurses Association, California Chapter, and has presented nationally on improving medication adherence, the science of cannabinoids in clinical practice, emerging psychedelic assisted psychotherapy modalities, treatment-resistant depression, diagnosis and treatment of bipolar disorder, and the art and science of psychopharmacologic practice.

Presentation(s):

Send Email for Andrew Penn


Assets

Tantalizingly Close: An Update on Emerging Psychedelic Research and a Report from a Psychedelic Psychotherapist Trainee



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Tantalizingly Close: An Update on Emerging Psychedelic Research and a Report from a Psychedelic Psychotherapist Trainee